Randomised Trial to Compare the Rates of Disease-Free Survival in Margine-Positive Patients After Radical Prostatectomy With or Without Adjuvant Post-Operative Radiotherapy

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Related Post

26 March, 2026

TROG welcomes new Board members and President-Elect

LATEST NEWS: 26 March 2026 We are delighted to

26 March, 2026

TROG’S 38th ASM puts focus on driving innovative trials

LATEST NEWS: 26 March 2026 TROG’s 2026 Annual Scientific